Madison Area Lyme Support Group

Pfizer and Valneva have advanced their experimental Lyme disease vaccine, PF-07307405 (LB6V, formerly VLA15), using the same core biological mechanism that sparked autoimmune arthritis concerns, lawsuits, and the eventual withdrawal of the only previous Lyme vaccine, LYMErix.

The jab works by forcing the body to produce antibodies against a bacterial protein that resembles a protein found in your own joint tissue, meaning those antibodies may also recognize similar structures in your joints and trigger an immune response there.

That means a mechanism previously tied to immune responses against joint tissue—producing Lyme-like symptoms—is now being brought back and positioned for broad public rollout.

Moreover, current data tracks antibody levels in the bloodstream over months, but does not map where those antibodies distribute in human tissues or how repeated boosting affects immune activity over the long term.  (See link for article)

_______________

**Comment**

Great article.  Really.  I wish I could have said it better.

If the above information doesn’t scare you enough – catch this: the vaccine forces the body to produce large quantities of anti-OspA IgG that remain inactive UNTIL a tick bites you, then the activity takes place INSIDE the tick.  Come again? 

To further the horror, the SAME molecular OspA mimicry in LYMRrix is in in the Pfizer Lyme vaccine, only this new vaccine expands the design across SIX borrelia serotypes.  Translation: even more than the estimated 30% of vaccinated people could get treatment resistant arthritis as a result of covering more serotypes of Bb AND due to the necessary boosters.

And to pound the nail in the coffin for good, reported adverse events were declared to be unrelated to the vaccine by investigators who all worked for Pfizer!  

Fleetwood does all of us a favor by critically looking at the study and exposing the fact there isn’t data showing tissue distribution and long term effects, especially after repeated exposure – the SAME exact blind spots LYMErix had…..

History repeats itself……yet again.